Stent with reduced profile

Information

  • Patent Grant
  • 8790388
  • Patent Number
    8,790,388
  • Date Filed
    Friday, March 2, 2012
    12 years ago
  • Date Issued
    Tuesday, July 29, 2014
    9 years ago
Abstract
Medical devices, systems, and techniques are described for reducing the profile of a stent. In one example, a stent having a reduced state and an expanded state includes a plurality of interconnected annular rings arranged about a longitudinal axis, each of the plurality of annular bands comprising a plurality of peaks and a plurality of troughs, wherein in the reduced state, at least one of the plurality of peaks of at least one of the plurality of rings is positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance, and wherein in the expanded state, the plurality of peaks of the stent being positioned at substantially the same distance from the longitudinal axis.
Description
TECHNICAL FIELD

The disclosure relates to endoprosthesis devices for implantation within a body vessel and delivery systems for delivering such devices.


BACKGROUND

A stent is a medical device introduced to a body lumen and is well known in the art. Typically, a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e., by so-called “minimally invasive techniques” in which the stent in a radially reduced configuration, optionally restrained in a radially compressed configuration by a sheath and/or catheter, is delivered by a stent delivery system or “introducer” to the site where it is required. The introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means.


Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).


SUMMARY

In general, this disclosure describes medical devices, systems, and techniques that allow portions of a stent to be folded within a balloon of a stent delivery system. In particular, the various medical devices, systems, and techniques described throughout this disclosure allow one or more peaks and/or troughs of a stent to be folded into a balloon fold of a pleated delivery balloon. In this manner, a profile of the stent can be reduced when the stent is crimped onto the balloon.


In one example, the disclosure is directed to a stent delivery system comprising a catheter comprising an expandable balloon, the balloon having a pleated state and an unpleated state, the balloon having at least two pleats in the pleated state, adjacent pleats of a balloon being separated by a fold in the pleated state, and a stent having a reduced state and an expanded state. The stent comprises a plurality of interconnected annular rings arranged about a longitudinal axis, each of the plurality of annular bands comprising a plurality of peaks and a plurality of troughs, wherein in the reduced state and positioned on the balloon, at least one of the plurality of peaks of at least one of the plurality of rings extends into a fold of the balloon in the pleated state, the at least one peak being positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance, and wherein in the expanded state, the plurality of peaks of the stent being positioned at substantially the same distance from the longitudinal axis.


In another example, the disclosure is directed to a stent having a reduced state and an expanded state, the stent comprising a plurality of interconnected annular rings arranged about a longitudinal axis, each of the plurality of annular bands comprising a plurality of peaks and a plurality of troughs, wherein in the reduced state, at least one of the plurality of peaks of at least one of the plurality of rings is positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance, and wherein in the expanded state, the plurality of peaks of the stent being positioned at substantially the same distance from the longitudinal axis.


The details of one or more aspects of the disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a side view of a stent delivery system that may be used in accordance with various techniques of this disclosure.



FIG. 2A is an isometric view of one example annular ring of a stent that can be used to implement various techniques of this disclosure.



FIG. 2B is a side view of the example annular ring depicted in FIG. 2A.



FIG. 2C is an end view of the example annular ring depicted in FIG. 2A.



FIG. 3A is an isometric view of the example annular ring depicted in FIG. 2A in an expanded state.



FIG. 3B is a side view of the example annular ring depicted in FIG. 3A.



FIG. 3C is an end view of the example annular ring depicted in FIG. 3A.



FIGS. 4A-4B are perspective views of a balloon in an unpleated state and a pleated state, respectively, that may be used in conjunction with the stent delivery system shown in FIG. 1.



FIG. 5A is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure.



FIG. 5B is a side view of the example annular ring depicted in FIG. 4A.



FIG. 5C is an end view of the example annular ring depicted in FIG. 4A.



FIG. 6A is a perspective view of one example of a portion of an annular ring.



FIG. 6B is a perspective view of another example of a portion of an annular ring.



FIG. 7A is a perspective view of an example stent for use with a pleated balloon, in accordance with this disclosure.



FIG. 7B is a cross-sectional view of the example stent and balloon depicted in FIG. 6A.



FIG. 8A is a perspective view of another example stent for use with a pleated balloon, in accordance with this disclosure.



FIG. 8B is a cross-sectional view of the example stent and balloon depicted in FIG. 7A.



FIG. 9 is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure.



FIG. 10A is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure.



FIG. 10B is a side view of the example annular ring depicted in FIG. 10A.



FIG. 10C is an end view of the example annular ring depicted in FIG. 10A.



FIG. 11A is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure.



FIG. 11B is a side view of the example annular ring depicted in FIG. 11A.



FIG. 11C is an end view of the example annular ring depicted in FIG. 11A.





DETAILED DESCRIPTION

This disclosure describes medical devices, systems, and techniques that allow portions of a stent to be folded into a balloon fold of a delivery balloon. As such, using certain techniques of this disclosure, a portion of the stent can be embedded within a fold of the delivery balloon during the folding process. Embedding a portion of the stent within a fold of the balloon provides one or more advantages over designs that do not utilize such techniques. For example, embedding a portion of the stent within a fold of the balloon reduces the profile of the stent in a crimped state. In addition, embedding a portion of the stent within a fold of the balloon helps secure the stent to the balloon.



FIG. 1 is a side view of a stent delivery system that may be used in accordance with various techniques of this disclosure. As seen in FIG. 1, stent delivery system 10 includes a catheter 12 having distal end 14 upon which a delivery balloon and stent may be secured in order to deliver the stent to a site within a patient's body. Stent delivery systems such as stent delivery system 10 are well known and, for purposes of conciseness, will not be described in detail in this disclosure.



FIG. 2A is an isometric view of one example annular ring of a stent that can be used to implement various techniques of this disclosure. In particular, the example annular ring of FIG. 2A, shown generally at 20, includes a plurality of peaks 22A-22G (collectively referred to in this disclosure as “peaks 22”) and a plurality of troughs 24A-24G (collectively referred to in this disclosure as “troughs 24”) created by interconnected struts 25. As seen in FIG. 2A, annular band 20 is arranged about longitudinal axis 26 and defines a cylindrical volume, represented by dashed lines 28A and 28B in FIG. 2B (collectively referred to in this disclosure as “lines 28”). The cylindrical volume is defined by the unbent peaks 22 and troughs 24 of annular ring 20. Additionally, line 28A defines a proximal end of annular band 20 and line 28B defines a distal end of annular band 20.


In accordance with this disclosure, at least one of the peaks and/or troughs of an annular ring of a stent is configured to bend inward into the cylindrical volume defined by the ring and into a balloon fold of a balloon, i.e., the space between adjacent pleats of a pleated balloon. In FIG. 2A, peak 22H of ring 20 bends inward into the cylindrical volume defined by the ring. Although not depicted in FIG. 2A, peak 22H bends into a balloon fold when placed onto a pleated delivery balloon. In this manner, when in a reduced state and positioned on the balloon, a first proximal end of at least one of the plurality of peaks or troughs of the stent extends into a fold of the balloon in the pleated state, the at least one peak being positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance.


Each of the plurality of rings 20 has a respective proximal end 27 and a respective distal end 31. In accordance with certain techniques of this disclosure, when a stent is in a reduced state, and thus when ring 20 is in a reduced state, as shown in FIGS. 2A-2C, one or more of the plurality of peaks of the stent, e.g., bent peak 22H, is positioned such that bent peak 22H is a first distance from longitudinal axis 26, e.g., distance D1, and another one of the plurality of peaks, e.g., unbent peak 22E, is positioned a second distance from longitudinal axis 26, e.g., distance D2, where the first distance, e.g., distance D1, is less than the second distance, e.g., distance D2. In this manner, one or more of the plurality of peaks of the stent extends into a fold of a balloon in a pleated state. That is, when the example configuration depicted in FIG. 2A is positioned on a pleated balloon, bent peak 22H extends into a fold of the balloon (e.g., fold 46 of balloon 30 in FIG. 4B).


In some example configurations, both a peak and a trough can be bent to extend into a fold of a pleated balloon. For example, in addition to peak 22H of FIG. 2A being bent and thus positioned at a distance from longitudinal axis 26 that is greater than the distance of unbent peaks, e.g., unbent peak 22E, from longitudinal axis 26, a trough of ring 20 can similarly be bent inward. For example, when a stent is in a reduced state, trough 24E can be bent inward such that it is positioned at a third distance from longitudinal axis 26 while unbent troughs, e.g., trough 24B, are positioned at a fourth distance from longitudinal axis 26, where the third distance is less than the fourth distance. In this manner, a ring can include at least one bent peak and at least one bent trough.


As shown and described in more detail below, configuring at least one peak and/or trough of a ring of a stent to bend inward into a balloon fold reduces the profile of the stent after crimping by minimizing the number of peaks (or troughs) that can interfere with another peak (or trough) during the crimping process. A stent can only be crimped to the point that its peaks or troughs begin to touch one another, thereby limiting the extent to which the stent's size can be reduced by crimping. In accordance with this disclosure, by bending one or more peaks and/or troughs of one or more annular rings of a stent into a balloon fold prior to crimping, the peaks and/or troughs are essentially eliminated from the circumference of the stent. In this manner, the stent can be crimped to a smaller size than would otherwise be achievable, thereby reducing the profile of the stent.


A peak or trough of a ring, e.g., peak 22H of ring 20, can be configured to bend inward and extend into a balloon fold of a balloon using various techniques in accordance with this disclosure. In one example, peaks or troughs of a ring, e.g., peak 22H of ring 20, are bent inward by folding the peak(s) or trough(s) at particular portions of struts 25. These portions of struts 25, referred to as fold lines, are depicted in FIG. 2A at 29A and 29B (referred to generally in this disclosure as “fold lines 29”). Although only two fold lines 29A and 29B are depicted in FIG. 2A, annular ring 20 can have more fold lines 29 or only a single fold line 29. As seen in FIG. 2A, peak 22H of ring 20 is bent inward into the cylindrical volume defined by ring 20 by folding at fold lines 29A, 29B, as indicated by the fact that the struts adjacent trough 24G are closer to each other than struts adjacent other troughs of ring 20, e.g., trough 24F.


Peaks or troughs of a ring can be folded at fold lines 29 using various techniques in accordance with this disclosure. In one example, the material at one or more portions of one or more struts of a ring can be reduced in order to create portion(s) that are thinner than the remainder of the strut. For example, in FIG. 2A, material near fold line 29A and/or fold line 29B can be reduced such that a width of strut 25 is thinner near the fold line than elsewhere along on the strut. As another example, in FIG. 2A, material near fold line 29A and/or fold line 29B can be reduced such that a thickness of strut 25 is thinner near the fold line than elsewhere along on the strut. The strut can be formed by laser cutting, chemical etching, electroforming or stamping of a tube. In this manner, the geometry of the stent can be configured to allow peaks and/or troughs to be folded. These techniques are shown and described in more detail below with respect to FIGS. 6A and 6B.


In another example folding technique, rather than configuring the geometry of the stent to allow peaks and/or troughs to be folded in the manner described throughout this disclosure, crimping techniques are employed instead. In accordance with this disclosure, crimping techniques are used that bend one or more peaks and/or troughs inward into the cylindrical volume defined by the ring and into a balloon fold of a balloon. In one example crimping process, a mold is employed, e.g., a clamshell mold, that includes pins that push certain portions of a stent below other portions as the mold is closed in order to bent certain peaks into folds of the balloon.


Any suitable stent material may be used in the manufacture of the rings and stents described in this disclosure. Examples of such materials include metals such as stainless steel, tantalum, elgiloy and shape memory metals such as nitinol and shape memory polymers. The rings and stents may also be made of suitable polymeric materials.



FIG. 2B is a side view of the example annular ring 20 depicted in FIG. 2A. Specifically, FIG. 2B depicts ring 20 arranged about longitudinal axis 26 and having a peak, namely peak 22H, bending inward into the cylindrical volume defined by the ring, represented by dashed lines 28.



FIG. 2C is an end view of the example annular ring 20 depicted in FIG. 2A. In particular, FIG. 2C depicts ring 20 arranged about longitudinal axis 26 and having a peak, namely peak 22H, bending inward into the cylindrical volume defined by the ring (not shown in FIG. 2B).



FIG. 3A is an isometric view of the example annular ring depicted in FIG. 2A in an expanded state. In the expanded state, peak 22H (which was previously bent in FIG. 2A) has expanded outwardly away from longitudinal axis 26 such that peak 22h is positioned at substantially the same distance from longitudinal axis 26 as previously unbent peaks, e.g., peak 22E. In other words, in FIG. 3A, D1 and D2 are approximately equal. FIGS. 3B and 3C are side and end views, respectively, of the example annular ring depicted in FIG. 3A.



FIGS. 4A-4B are perspective views of a delivery balloon in an unpleated state and a pleated state, respectively, that can be used in conjunction with the stent delivery system shown in FIG. 1. In FIG. 4A, delivery balloon 30 with balloon body 32, shown in an unpleated, or expanded state, can be secured to distal end 14 of catheter 12 (FIG. 1), e.g., by adhesive attachment of proximal end 34 of balloon 30 to an outer shaft of catheter 12 and distal end 36 of balloon 30 to an inner shaft of catheter 12.



FIG. 4B depicts delivery balloon 30 with balloon body 32 in a pleated state, prior to folding of the balloon. As depicted in FIG. 4B, balloon body 32 includes three pleats, namely pleats 40, 42, and 44. In other configurations, balloon body 32 includes fewer or more pleats. The balloon body, or balloon, has at least two pleats in the pleated state.


As mentioned above, using certain techniques of this disclosure, at least one of the peaks of an annular ring of a stent is configured to bend inward into the cylindrical volume defined by the ring and into a balloon fold of a balloon. In one example, a balloon fold is the area or space between adjacent pleats on a balloon. By way of specific example, FIG. 4B depicts balloon 30 having balloon fold 46 located between adjacent pleats 40, 44. Similarly, balloon 30 has two other balloon folds (not shown) located between adjacent pleats 40, 42 and adjacent pleats 42, 44. By configuring at least one peak of annular rings of a stent, e.g., peak 22H of annular ring 30 of FIGS. 2A-2C, to bend inward into the cylindrical volume defined by the ring and into a balloon fold of a balloon, e.g., balloon fold 46 of balloon 30 of FIG. 4B, the profile of the stent is reduced in a crimped state. The combination of a stent and balloon is shown and described in detail below with respect to FIGS. 7A and 8A.



FIG. 5A is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure. In particular, FIG. 5A depicts annular ring 50 arranged about longitudinal axis 26 and configured to have four peaks that bend inward into a cylindrical volume defined by ring 50 and into a balloon fold of a balloon. In FIG. 5A, peaks 22B, 22D, 22F, and 22H of ring 20 bend inwards into the cylindrical volume defined by the ring. As shown below in FIG. 6, peaks 22B, 22D, 22F, and 22H bend into a balloon fold when placed onto a pleated delivery balloon. FIGS. 5B and 5C depict a side view and an end view, respectively, of the example annular ring depicted in FIG. 5A.



FIG. 6A is a perspective view of one example of a portion of an annular ring. In particular, FIG. 6A depicts fold lines 29 in a portion of an annular ring, e.g., annular rings 20 or 50. In the example configuration depicted in FIG. 6A, fold lines 29 are formed by reducing a portion of the thickness of strut 25, e.g., a notch in strut 25, in the bend area. By reducing a portion of the thickness of strut 25, peaks 22A and 22G can be compressed toward each other, thereby allowing peak 22H to be bent so that it extends into a fold of a pleated balloon.



FIG. 6B is a perspective view of another example of a portion of an annular ring. In particular, FIG. 6B depicts fold lines 29 in a portion of an annular ring, e.g., annular rings 20 or 50. In the example configuration depicted in FIG. 6B, fold lines 29 are formed by reducing a portion of the width of strut 25, e.g., a notch in strut 25, in the bend area. By reducing a portion of the width of strut 25, peak 22H can be compressed and bent so that it extends into a fold of a pleated balloon.


In other example configurations, strut(s) 25 can be formed into a bent shape. In such an example configuration, the bent shape reduces or eliminates the need for a notch or other reduction in a portion of strut 25.



FIG. 7A is a perspective view of an example stent for use with a pleated balloon, in accordance with this disclosure. In particular, FIG. 7A depicts a stent delivery system, shown generally at 60, that comprises a stent, shown generally at 62, having a plurality of interconnected annular rings 20A-20F, e.g., annular rings 20 of FIGS. 2A-2C, positioned on expandable balloon 64 and arranged about a longitudinal axis, shown generally at 70. Balloon 64 is depicted in a pleated state and includes adjacent pleats 65 and 66. Adjacent pleats 65, 66 are separated by fold 68.


Stent 62, depicted in a reduced in FIG. 7A, includes at least one peak, namely peak 22H, extending into fold 68 of pleated balloon 64. Peak 22H of ring 20A, for example, extends into fold 68 by being bent inward along fold line 29. As shown and described above in detail with respect to FIGS. 2A-2C, at least one of annular bands 20 of stent 62 includes a peak, e.g., peak 22H, positioned a first distance from longitudinal axis 70 and another peak, e.g., peak 22G, positioned a second distance from longitudinal axis 70, the first distance being less than the second distance. When stent 62 is in an expanded state, the plurality of peaks 22 of stent 62 are positioned at substantially the same distance from longitudinal axis 70, as shown and described above with respect to FIGS. 3A-3C. FIG. 7B is a cross-sectional view of the example stent and balloon depicted in FIG. 7A, taken along line A-A.


In this manner, a portion of stent 62 is embedded within a fold of the balloon, thereby reducing the profile of stent 62 in a reduced or crimped state. In addition, embedding a portion of the stent within a fold of the balloon helps secure the stent to the balloon.


Although stent 62 is depicted as having six rings 20A-20F, stent 62 is not limited to such a configuration. Rather, stent 62 can have more or fewer rings 20. Additionally, although pleated balloon 64 is depicted as having two adjacent pleats and a fold in between, balloon 64 can have more pleats, and thus more folds, thereby allowing more peaks in a ring to be extend into folds. Further, it should be noted that although each of rings 20A-20F includes a peak that extends into fold 68 of balloon 64, the disclosure is not so limited. Rather, in some examples, only one ring, e.g., ring 20A, of stent 62 includes a bent peak that extends into a fold. In other example configurations, multiple rings 20 of stent 62, but less than all rings 20, include a bent peak that extends into a fold.



FIG. 8A is a perspective view of another example stent for use with a pleated balloon, in accordance with this disclosure. In particular, FIG. 8A depicts a stent delivery system, shown generally at 80, that comprises a stent, shown generally at 82, having a plurality of interconnected annular rings 20A-20F, e.g., annular rings 20 of FIGS. 2A-2C, positioned on expandable balloon 64 and arranged about a longitudinal axis, shown generally at 70. Balloon 64 is depicted in a pleated state and includes pleats 84, 86, and 88. Adjacent pleats 84, 86 are separated by fold 88 and adjacent pleats 86, 88 are separated by fold 90.


Stent 82, depicted in a reduced in FIG. 8A, includes at least one peak, namely peak 22H, extending into fold 88 of pleated balloon 64. Peak 22H of ring 20A, for example, extends into fold 88 by being bent inward along fold line 29C. As shown and described above in detail with respect to FIGS. 2A-2C, at least one of annular bands 20 of stent 82 includes a peak, e.g., peak 22H, positioned a first distance from longitudinal axis 70 and another peak, e.g., peak 22G, positioned a second distance from longitudinal axis 70, the first distance being less than the second distance. When stent 62 is in an expanded state, the plurality of peaks 22 of stent 82 are positioned at substantially the same distance from longitudinal axis 70, as shown and described above with respect to FIGS. 3A-3C.


In addition, in the example shown in FIG. 8A, at least one of annular bands 20 of stent 82 includes a trough, e.g., trough 24F, that extends into a fold, e.g., fold 88, of pleated balloon 64. Trough 24F is positioned a third distance from longitudinal axis 70 and another trough, e.g., trough 24G, is positioned a fourth distance from longitudinal axis 70, the third distance being less than the fourth distance. When stent 82 is in an expanded state, the plurality of troughs 24 of stent 82 are positioned at substantially the same distance from longitudinal axis 70, as shown and described above with respect to FIGS. 3A-3C. FIG. 8B is a cross-sectional view of the example stent and balloon depicted in FIG. 8A, taken along line B-B.



FIG. 9 is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure. In FIG. 9, in accordance with this disclosure, bent peak 22H of ring 100 is configured to expand before the unbent peaks, e.g., peaks 22A-22G, when a stent comprising ring 100 transitions from a reduced state to an expanded state. Ring 100 forms part of a stent in a reduced state. FIGS. 3A-3C, described in detail above, depict a ring in an expanded state.


In accordance with certain techniques of this disclosure, bent peak 22H of ring 100 of FIG. 9 is configured to expand before the unbent peaks, e.g., peaks 22A-22G. That is, by constructing struts of the bent peak to be thinner than struts of the unbent peaks, the bent peaks can open prior to the unbent peaks as the stent expands from a reduced state. In FIG. 9, unbent peaks, e.g., unbent peak 22G, is formed by struts 25A having a width W1 and bent peak 22H is formed by struts 25B having a width W2, where width W1 is greater than width W2. Such a configuration allows a bent peak, e.g., peak 22H, that extends into the fold of a balloon, e.g., fold 68 of balloon 64, to expand outwardly prior to the remaining unbent peaks, e.g., 22A-22G, during an expansion from the reduced state to the expanded state. Additional detail regarding stents that include struts with varying widths can be found in U.S. Patent Application No. 61/448,843, entitled “Low Strain High Strength Stent” and filed on Mar. 3, 2011, incorporated herein by reference in its entirety.


It should be noted that although one peak, namely peak 22H, is depicted in FIG. 9 as being bent, two or more peaks can be bent inward, as described in detail above. As such, each bent peak can comprise struts that are thinner than the struts of unbent peaks.



FIG. 10A is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure. In particular, FIG. 10A depicts annular ring 110 arranged about longitudinal axis 26 and configured to have two peaks that bend inward into a cylindrical volume defined by ring 110 and into a balloon fold of a balloon. In FIG. 10A, peaks 22D and 22H of ring 110 bend inwards into the cylindrical volume defined by the ring. FIGS. 10B and 10C depict a side view and an end view, respectively, of the example annular ring depicted in FIG. 10A.



FIG. 11A is an isometric view of another example annular ring of a stent that can be used to implement various techniques of this disclosure. In particular, FIG. 11A depicts annular ring 110 arranged about longitudinal axis 26 and configured to have four peaks that bend inward into a cylindrical volume defined by ring 110 and into a balloon fold of a balloon. In FIG. 11A, peaks 22B, 22D, 22F, and 22H of ring 110 bend inwards into the cylindrical volume defined by the ring. Ring 110 is similar to ring 50 of FIGS. 5A-5C, except that bent peaks 22B, 22D, 22F, and 22H of ring 110 are deformed even more than the bent peaks of 50. Peaks 22B, 22D, 22F, and 22H of ring 110 can be deformed in the manner shown by adding additional fold lines 29, such as fold lines 29A-29C as seen best in FIG. 11C. FIGS. 11B and 11C depict a side view and an end view, respectively, of the example annular ring depicted in FIG. 11A.


In some examples, the stent, the delivery system or other portion of the assembly may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In other examples, at least a portion of the stent and/or adjacent assembly is at least partially radiopaque.


In some examples, at least a portion of the stent is configured to include one or more mechanisms for the delivery of a therapeutic agent. Often the agent will be in the form of a coating or other layer (or layers) of material placed on a surface region of the stent, which is adapted to be released at the site of the stent's implantation or areas adjacent thereto.


A therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.


The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined or modified for combination as desired. Various examples of the disclosure have been described. These and other examples are within the scope of the following claims.

Claims
  • 1. A stent delivery system comprising: a catheter comprising an expandable balloon, the balloon having a pleated state and an unpleated state, the balloon having at least two pleats in the pleated state, adjacent pleats of a balloon being separated by a fold in the pleated state; anda stent having a reduced state and an expanded state, the stent comprising a plurality of interconnected annular rings arranged about a longitudinal axis, each of the plurality of annular rings comprising a plurality of peaks and a plurality of troughs,wherein in the reduced state and positioned on the balloon, at least one of the plurality of peaks of at least one of the plurality of rings extends into a fold of the balloon in the pleated state the at least one peak being positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance,wherein in the expanded state, the plurality of peaks of the stent being positioned at substantially the same distance from the longitudinal axis,wherein the plurality of peaks are defined by a plurality of struts,wherein the at least one peak that extends into the fold comprises at least one first strut having a first thickness,wherein each of the remaining peaks of the annular band comprise at least one second strut having a second thickness, andwherein the first thickness is less than the second thickness.
  • 2. The stent delivery system of claim 1, wherein the at least one peak that extends into the fold comprises at least one first strut having a first width,wherein each of the remaining peaks of the annular ring comprise at least one second strut having a second width, andwherein the first width is less than the second width.
  • 3. The stent delivery system of claim 1, wherein the fold is a first fold of the balloon, andwherein at least one of the plurality of troughs of at least one of the plurality of rings extends into a second fold of the balloon in the pleated state, the at least one trough being positioned a third distance from the longitudinal axis, another one of the plurality of peaks being positioned a fourth distance from the longitudinal axis, the third distance being less than the fourth distance.
  • 4. The stent delivery system of claim 3, wherein the plurality of troughs are defined by a plurality of struts,wherein the at least one trough that extends into the fold comprises at least one first strut having a first thickness,wherein each of the remaining troughs of the annular ring comprise at least one second strut having a second thickness, andwherein the first thickness is less than the second thickness.
  • 5. The stent delivery system of claim 1, wherein in the reduced state and positioned on the balloon, at least one of the plurality of peaks of each of the plurality of rings extends into a fold of the balloon in the pleated state.
  • 6. The stent delivery system of claim 5, wherein the at least one peak that extends into the fold comprises at least one first strut having a first width,wherein each of the remaining peaks of the annular ring comprise at least one second strut having a second width, andwherein the first width is less than the second width.
  • 7. The stent delivery system of claim 1, wherein during an expansion from the reduced state to the expanded state, the at least one peak that extends into the fold is configured to expand outwardly prior to the remaining peaks.
  • 8. The stent delivery system of claim 7, wherein the at least one peak configured to expand outwardly prior to the remaining peaks comprises at least one strut having a first width,wherein the remaining peaks comprise a plurality of struts that each have a second width, andwherein the first width is less than the second width.
  • 9. A stent having a reduced state and an expanded state, the stent comprising: a plurality of interconnected annular rings arranged about a longitudinal axis, each of the plurality of annular rings comprising a plurality of peaks and a plurality of troughs,wherein in the reduced state, at least one of the plurality of peaks of at least one of the plurality of rings is positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance,wherein in the expanded state, the plurality of peaks of the stent being positioned at substantially the same distance from the longitudinal axis,wherein the plurality of peaks are defined by a plurality of struts,wherein the at least one peak positioned a first distance from the longitudinal axis comprises at least one first strut having a first thickness,wherein each of the remaining peaks of the annular band comprise at least one second strut having a second thickness, andwherein the first thickness is less than the second thickness.
  • 10. The stent of claim 9, wherein at least one of the plurality of troughs of at least one of the plurality of rings is positioned a third distance from the longitudinal axis, another one of the plurality of peaks being positioned a fourth distance from the longitudinal axis, the third distance being less than the fourth distance.
  • 11. The stent of claim 10, wherein the plurality of troughs are defined by a plurality of struts,wherein the at least one troughs that extends into the fold comprises at least one first strut having a first thickness,wherein each of the remaining troughs of the annular band comprise at least one second strut having a second thickness, andwherein the first thickness is less than the second thickness.
  • 12. The stent of claim 10, wherein the plurality of troughs are defined by a plurality of struts,wherein the at least one trough positioned a third distance from the longitudinal axis comprises at least one first strut having a first width,wherein each of the remaining troughs of the annular ring comprise at least one second strut having a second width, andwherein the first width is less than the second width.
  • 13. The stent of claim 9, wherein the at least one peak positioned a first distance from the longitudinal axis comprises at least one first strut having a first width,wherein each of the remaining peaks of the annular ring comprise at least one second strut having a second width, andwherein the first width is less than the second width.
  • 14. The stent of claim 9, wherein during an expansion from the reduced state to the expanded state, the at least one peak that is positioned the first distance from the longitudinal axis in the reduced state is configured to expand outwardly prior to the remaining peaks.
  • 15. The stent of claim 14, wherein the at least one peak configured to expand outwardly prior to the remaining peaks comprises at least one strut having a first width,wherein the remaining peaks comprise a plurality of struts that each have a second width, andwherein the first width is less than the second width.
  • 16. A stent having a reduced state and an expanded state, the stent comprising: a plurality of interconnected annular rings arranged about a longitudinal axis, each of the plurality of annular rings comprising a plurality of peaks and a plurality of troughs,wherein in the reduced state, at least one of the plurality of peaks of at least one of the plurality of rings is positioned a first distance from the longitudinal axis, another one of the plurality of peaks being positioned a second distance from the longitudinal axis, the first distance being less than the second distance,wherein in the expanded state, the plurality of peaks of the stent being positioned at substantially the same distance from the longitudinal axis,wherein the plurality of peaks are defined by a plurality of struts,wherein the at least one peak positioned a first distance from the longitudinal axis comprises at least one first strut having a first width,wherein each of the remaining peaks of the annular band comprise at least one second strut having a second width, andwherein the first width is less than the second width.
  • 17. The stent of claim 16, wherein at least one of the plurality of troughs of at least one of the plurality of rings is positioned a third distance from the longitudinal axis, another one of the plurality of peaks being positioned a fourth distance from the longitudinal axis, the third distance being less than the fourth distance.
  • 18. The stent of claim 16, wherein during an expansion from the reduced state to the expanded state, the at least one peak that is positioned the first distance from the longitudinal axis in the reduced state is configured to expand outwardly prior to the remaining peaks.
US Referenced Citations (318)
Number Name Date Kind
2836181 Tapp May 1958 A
3105492 Jeckel Oct 1963 A
3272204 Artandi et al. Sep 1966 A
3490975 Lightwood et al. Jan 1970 A
3509883 Dibelius May 1970 A
3526228 Lyng Sep 1970 A
3562820 Braun Feb 1971 A
3635215 Shea et al. Jan 1972 A
3657744 Ersek Apr 1972 A
3771526 Rudle Nov 1973 A
3868956 Alfidi et al. Mar 1975 A
3993078 Bergentz et al. Nov 1976 A
4078167 Banas et al. Mar 1978 A
4127761 Pauley et al. Nov 1978 A
4130904 Whalen Dec 1978 A
4140126 Choudhury Feb 1979 A
4141364 Schultze Feb 1979 A
4164045 Bokros et al. Aug 1979 A
4214587 Sakura, Jr. Jul 1980 A
4300244 Bokros Nov 1981 A
4313231 Koyamada Feb 1982 A
4319363 Ketharanathan Mar 1982 A
4425908 Simon Jan 1984 A
4441215 Kaster Apr 1984 A
4470407 Hussein Sep 1984 A
4501264 Rockey Feb 1985 A
4503569 Dotter Mar 1985 A
4512338 Balko et al. Apr 1985 A
4535770 Lemole Aug 1985 A
4550447 Seiler, Jr. et al. Nov 1985 A
4553545 Maass et al. Nov 1985 A
4560374 Hammerslag Dec 1985 A
4580568 Gianturco Apr 1986 A
4597389 Ibrahim et al. Jul 1986 A
4647416 Seiler, Jr. et al. Mar 1987 A
4649922 Wiktor Mar 1987 A
4655771 Wallsten Apr 1987 A
4655776 Lesinski Apr 1987 A
4665918 Garza et al. May 1987 A
4681110 Wiktor Jul 1987 A
4693721 Ducheyne Sep 1987 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4740207 Kreamer Apr 1988 A
4760849 Kropf Aug 1988 A
4762128 Rosenbluth Aug 1988 A
4768507 Fischell et al. Sep 1988 A
4769029 Patel Sep 1988 A
4771773 Kropf Sep 1988 A
4776337 Palmaz Oct 1988 A
4786507 Schmidt Nov 1988 A
4787899 Lazarus Nov 1988 A
4795458 Regan Jan 1989 A
4795465 Marten Jan 1989 A
4800882 Gianturco Jan 1989 A
4820298 Leveen et al. Apr 1989 A
4830003 Wolff et al. May 1989 A
4842575 Hoffman, Jr. et al. Jun 1989 A
4848343 Wallsten et al. Jul 1989 A
4851009 Pinchuk Jul 1989 A
4856516 Hillstead Aug 1989 A
4872874 Taheri Oct 1989 A
4877030 Beck et al. Oct 1989 A
4878906 Lindemann et al. Nov 1989 A
4886062 Wiktor Dec 1989 A
4913141 Hillstead Apr 1990 A
4922905 Strecker May 1990 A
4950227 Savin et al. Aug 1990 A
4950258 Kawai et al. Aug 1990 A
4994071 MacGregor Feb 1991 A
5015253 MacGregor May 1991 A
5019090 Pinchuk May 1991 A
5035706 Giantureo et al. Jul 1991 A
5037392 Hillstead Aug 1991 A
5059211 Stack et al. Oct 1991 A
5061275 Wallsten et al. Oct 1991 A
5064435 Porter Nov 1991 A
5091205 Fan Feb 1992 A
5091211 Richard Feb 1992 A
5092877 Pinchuk Mar 1992 A
5102417 Palmaz Apr 1992 A
5104399 Lazarus Apr 1992 A
5104404 Wolff Apr 1992 A
5108415 Pinchuk et al. Apr 1992 A
5108417 Sawyer Apr 1992 A
5122154 Rhodes Jun 1992 A
5133732 Wiktor Jul 1992 A
5135536 Hillstead Aug 1992 A
5139480 Hickle et al. Aug 1992 A
5147385 Beck et al. Sep 1992 A
5147400 Kaplan et al. Sep 1992 A
5158548 Lau et al. Oct 1992 A
5163952 Froix Nov 1992 A
5195984 Schatz Mar 1993 A
5197978 Hess Mar 1993 A
5217483 Tower Jun 1993 A
5226913 Pinchuk Jul 1993 A
5282823 Schwartz et al. Feb 1994 A
5282824 Gianturco Feb 1994 A
5292331 Boneau Mar 1994 A
5304200 Spaulding Apr 1994 A
5344425 Sawyer Sep 1994 A
5354308 Simon et al. Oct 1994 A
5354309 Schnepp-Pesch et al. Oct 1994 A
5356423 Tihon et al. Oct 1994 A
5366504 Andersen et al. Nov 1994 A
5383892 Cardon et al. Jan 1995 A
5389106 Tower Feb 1995 A
5405377 Cragg Apr 1995 A
5411552 Andersen et al. May 1995 A
5443498 Fontaine Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5522881 Lentz Jun 1996 A
5591197 Orth et al. Jan 1997 A
5609627 Goicoechea et al. Mar 1997 A
5628782 Myers et al. May 1997 A
5630829 Lauterjung May 1997 A
5632771 Boatman et al. May 1997 A
5643580 Subramaniam Jul 1997 A
5649952 Lam Jul 1997 A
5697971 Fischell et al. Dec 1997 A
5707386 Schnepp-Pesch et al. Jan 1998 A
5716365 Goicoechea et al. Feb 1998 A
5716393 Lindenberg et al. Feb 1998 A
5718713 Frantzen Feb 1998 A
5725547 Chuter Mar 1998 A
5725572 Lam et al. Mar 1998 A
5735893 Lau et al. Apr 1998 A
5741317 Ostrow Apr 1998 A
5741327 Frantzen Apr 1998 A
5746745 Abele et al. May 1998 A
5755770 Ravenscroft May 1998 A
5755776 Al-Saadon May 1998 A
5755781 Jayaraman May 1998 A
5766238 Lau et al. Jun 1998 A
5776161 Globerman Jul 1998 A
5776183 Kanesaka et al. Jul 1998 A
5800520 Fogarty et al. Sep 1998 A
5800521 Orth Sep 1998 A
5807404 Richter Sep 1998 A
5810872 Kanesaka et al. Sep 1998 A
5814063 Freitag Sep 1998 A
5824046 Smith et al. Oct 1998 A
5824059 Wijay Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5836966 St. Germain Nov 1998 A
5843168 Dang Dec 1998 A
5855597 Jayaraman Jan 1999 A
5855600 Alt Jan 1999 A
5858556 Eckert et al. Jan 1999 A
5861027 Trapp Jan 1999 A
5868780 Lashinski et al. Feb 1999 A
5873906 Lau et al. Feb 1999 A
5876432 Lau et al. Mar 1999 A
5879381 Moriuchi et al. Mar 1999 A
5895407 Jayaraman Apr 1999 A
5911754 Kanesaka et al. Jun 1999 A
5913895 Burpee et al. Jun 1999 A
5922020 Klein et al. Jul 1999 A
5922021 Jang Jul 1999 A
5925061 Ogi et al. Jul 1999 A
5935162 Dang Aug 1999 A
5938697 Killion et al. Aug 1999 A
5948016 Jang Sep 1999 A
5954743 Jang Sep 1999 A
5980553 Gray et al. Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
6001123 Lau Dec 1999 A
6013854 Moriuchi Jan 2000 A
6017365 VonOepen Jan 2000 A
6022371 Killion Feb 2000 A
6022374 Imran Feb 2000 A
6027527 Asano et al. Feb 2000 A
6042597 Kveen et al. Mar 2000 A
6042606 Frantzen Mar 2000 A
6053941 Lindenberg et al. Apr 2000 A
6056775 Borghi et al. May 2000 A
6059822 Kanesaka et al. May 2000 A
6068656 Von Oepen May 2000 A
6106548 Roubin et al. Aug 2000 A
6113627 Jang Sep 2000 A
6117165 Becker Sep 2000 A
6129755 Mathis et al. Oct 2000 A
6132460 Thompson Oct 2000 A
6132461 Thompson Oct 2000 A
6146403 St. Germain Nov 2000 A
6162245 Jayaraman Dec 2000 A
6168619 Dinh et al. Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6190403 Fischell et al. Feb 2001 B1
6190406 Duerig et al. Feb 2001 B1
6193747 von Oepen Feb 2001 B1
6203569 Wijay Mar 2001 B1
6206911 Milo Mar 2001 B1
6210429 Vardi et al. Apr 2001 B1
6221099 Andersen et al. Apr 2001 B1
6231598 Berry et al. May 2001 B1
6245101 Drasler et al. Jun 2001 B1
6261319 Kveen et al. Jul 2001 B1
6264685 Ahari Jul 2001 B1
6264688 Herklotz et al. Jul 2001 B1
6272370 Gillies et al. Aug 2001 B1
6280385 Melzer et al. Aug 2001 B1
6287331 Heath Sep 2001 B1
6287336 Globerman et al. Sep 2001 B1
6290721 Heath Sep 2001 B1
6293966 Frantzen Sep 2001 B1
6299635 Frantzen Oct 2001 B1
6309414 Rolando et al. Oct 2001 B1
6312459 Huang et al. Nov 2001 B1
6315791 Gingras et al. Nov 2001 B1
6325825 Kula et al. Dec 2001 B1
6325826 Vardi et al. Dec 2001 B1
6327772 Zadno-Azizi et al. Dec 2001 B1
6330884 Kim Dec 2001 B1
6331188 Lau et al. Dec 2001 B1
6331189 Wolinsky et al. Dec 2001 B1
6331190 Shokoohi et al. Dec 2001 B1
6334871 Dor et al. Jan 2002 B1
6336937 Vonesh et al. Jan 2002 B1
6340366 Wijay Jan 2002 B2
6340367 Stinson et al. Jan 2002 B1
6348065 Brown et al. Feb 2002 B1
6355057 DeMarais et al. Mar 2002 B1
6355058 Pacetti et al. Mar 2002 B1
6358274 Thompson Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6361759 Frayne et al. Mar 2002 B1
6379381 Hossainy et al. Apr 2002 B1
6395020 Ley et al. May 2002 B1
6402777 Globerman et al. Jun 2002 B1
6423090 Hancock Jul 2002 B1
6461380 Cox Oct 2002 B1
6471720 Ehr et al. Oct 2002 B1
6488703 Kveen et al. Dec 2002 B1
6520987 Plante Feb 2003 B1
6524335 Hartley et al. Feb 2003 B1
6524336 Papazolgou et al. Feb 2003 B1
6533808 Thompson Mar 2003 B1
6540775 Fischell et al. Apr 2003 B1
6540777 Stenzel Apr 2003 B2
6551351 Smith et al. Apr 2003 B2
6558415 Thompson May 2003 B2
6602282 Yan Aug 2003 B1
6610086 Kock et al. Aug 2003 B1
6613081 Kim et al. Sep 2003 B2
6629994 Gomez et al. Oct 2003 B2
6652579 Cox et al. Nov 2003 B1
6656215 Yanez et al. Dec 2003 B1
6663664 Pacetti Dec 2003 B1
6706062 Vardi et al. Mar 2004 B2
6730116 Wolinsky et al. May 2004 B1
6730117 Tseng et al. May 2004 B1
6776793 Brown et al. Aug 2004 B2
6818014 Brown et al. Nov 2004 B2
6821292 Pazienza et al. Nov 2004 B2
6846323 Yip et al. Jan 2005 B2
6854172 Kaese et al. Feb 2005 B2
6878162 Bales et al. Apr 2005 B2
6962603 Brown et al. Nov 2005 B1
6969402 Bales et al. Nov 2005 B2
6981986 Brown et al. Jan 2006 B1
7014654 Welsh et al. Mar 2006 B2
7031687 Kivekas et al. Apr 2006 B2
7204848 Brown et al. Apr 2007 B1
7223283 Chouinard May 2007 B2
7243408 Vietmeier Jul 2007 B2
7329277 Addonizio et al. Feb 2008 B2
7331986 Brown et al. Feb 2008 B2
7354450 Bicek et al. Apr 2008 B2
7404823 Gregorich et al. Jul 2008 B2
7534257 Richter May 2009 B2
7842080 Chouinard Nov 2010 B2
7988717 Brown et al. Aug 2011 B2
20010029397 Thompson Oct 2001 A1
20010039447 Pinchasik et al. Nov 2001 A1
20010044652 Moore Nov 2001 A1
20010056298 Brown et al. Dec 2001 A1
20020007212 Brown et al. Jan 2002 A1
20020022876 Richter et al. Feb 2002 A1
20020055770 Doran et al. May 2002 A1
20020095208 Gregorich et al. Jul 2002 A1
20020107562 Hart et al. Aug 2002 A1
20020111669 Pazienza et al. Aug 2002 A1
20020116049 Girton et al. Aug 2002 A1
20020120322 Thompson et al. Aug 2002 A1
20020123797 Majercak Sep 2002 A1
20020177893 Brown et al. Nov 2002 A1
20030004567 Boyle et al. Jan 2003 A1
20030018380 Craig et al. Jan 2003 A1
20030055485 Lee et al. Mar 2003 A1
20030176914 Rabkin et al. Sep 2003 A1
20030195606 Davidson et al. Oct 2003 A1
20030225448 Gerberding Dec 2003 A1
20040002753 Burgermeister et al. Jan 2004 A1
20040034402 Bales et al. Feb 2004 A1
20040044401 Bales et al. Mar 2004 A1
20040073291 Brown et al. Apr 2004 A1
20040088039 Lee et al. May 2004 A1
20040088044 Brown et al. May 2004 A1
20040111147 Rabkin et al. Jun 2004 A1
20040117002 Girton et al. Jun 2004 A1
20040143318 Tseng et al. Jul 2004 A1
20040204751 Fischell et al. Oct 2004 A1
20050060025 Mackiewicz et al. Mar 2005 A1
20050125051 Eidenschink et al. Jun 2005 A1
20050149168 Gregorich Jul 2005 A1
20060015173 Clifford et al. Jan 2006 A1
20060052864 Harder et al. Mar 2006 A1
20060271159 Gregorich et al. Nov 2006 A1
20070150048 Tischler Jun 2007 A1
20070219624 Brown et al. Sep 2007 A1
20080097579 Shanley et al. Apr 2008 A1
20080221661 Bidne et al. Sep 2008 A1
20090163994 Quigley et al. Jun 2009 A1
20100100166 Richter et al. Apr 2010 A1
20120172972 Meyer et al. Jul 2012 A1
20120226346 Boismier et al. Sep 2012 A1
Foreign Referenced Citations (56)
Number Date Country
2248718 Sep 1997 CA
29702671 Apr 1997 DE
29701758 May 1997 DE
29708689 Jul 1997 DE
29708879 Jul 1997 DE
29716476 Dec 1997 DE
29816878 Dec 1998 DE
0364737 Apr 1990 EP
0364787 Apr 1990 EP
0540290 May 1993 EP
0541443 May 1993 EP
0606165 Jul 1994 EP
0679372 Nov 1995 EP
0796597 Sep 1997 EP
0800801 Oct 1997 EP
0801933 Oct 1997 EP
0821920 Feb 1998 EP
0876806 Nov 1998 EP
0897698 Feb 1999 EP
0970664 Jan 2000 EP
0983753 Mar 2000 EP
1034751 Sep 2000 EP
1159934 Dec 2001 EP
1190685 Mar 2002 EP
1362564 Nov 2003 EP
6004175 Mar 1994 JP
6181993 Jul 1994 JP
9417754 Aug 1994 WO
9621404 Jul 1996 WO
9626689 Sep 1996 WO
9628116 Sep 1996 WO
9704721 Feb 1997 WO
9714375 Apr 1997 WO
9725937 Jul 1997 WO
9732543 Sep 1997 WO
9732544 Sep 1997 WO
9733534 Sep 1997 WO
9740780 Nov 1997 WO
9740781 Nov 1997 WO
9740782 Nov 1997 WO
9740783 Nov 1997 WO
9740784 Nov 1997 WO
9740874 Nov 1997 WO
9745073 Dec 1997 WO
9820810 May 1998 WO
9826732 Jun 1998 WO
9837833 Sep 1998 WO
9847447 Oct 1998 WO
9925273 May 1999 WO
9944535 Sep 1999 WO
0030563 Jun 2000 WO
0132099 May 2001 WO
0158386 Aug 2001 WO
02060344 Aug 2002 WO
2004032802 Apr 2004 WO
2008005535 Jan 2008 WO
Non-Patent Literature Citations (26)
Entry
Beyar et al, “The BeStent; The Parallel-Serial Jang Stents” , Handbook of Coronary Stents, Second Edition, 158-171 & 229-234 (1998).
Beyar et al “Newer Stents; Material and Designs” IAGS Proceedings 9(5): 363-371 (Jun. 1997).
Brochure Entitled Ave Micro Stent TM, Instructions for Use, by Applied Vascular Engineering, Inc., pp. 1-15.
Brochure Entitled “Micro Stent TM”, By Applied Vascular Engineering, Inc.
Brochure from Cook Incorporated regarding Gianturco-Rosch Biliary Z-Stents TM, 1989.
Cambridge Dictionary of Science and Technology, Cambridge University Pres. 128, Date Unknown.
Expandable Biliary Endoprosthesis: An Experimental Study, by Carrasco et al., AJR vol. 145, Dec. 1985, pp. 1279-1282.
Self-Expanding Stainless Street Biliary Stents, by Harold G. Coons, MD, Radiology 1989, vol. 170, No. 3 part 2, pp. 979-983.
Gianturco Expandable Metallic Biliary Stents: Results of a European Clinical Trial, by Irving, et al Interventional Radiology, vol. 172, No. 2, Aug. 1989, pp. 321-326.
Japanese Infringements Search on Articulated Expandable Stents, dated Jul. 12, 1995.
Manufacturing Processes for Engineering Materials, by Serope Kalpallian, Illinois Institute of Technology, Addison - Wesley Publishing Company, pp. 340, Date Unknown.
Improved Dilation Catheter Balloons, by Stanley B. Levy PhD., Journal of Clinical Engineering, vol. 11, No. 4, Jul.-Aug. 1986, pp. 291-296.
Engineering Fluid Mechanics, Third Edition, John A. Roberson and Clayton T Crowe, pp. 94 and pp. 414-421, Date Unknown.
Roguin et al Acute and 30 - Day Results of the Serpentine Balloon Expandable Stent Implantation in Simple and Complex Coronary Arterial Narrowing\, The American Journal of Cardiology, 80: 1155-1162 (Nov. 1997).
Roguin et al, “BeStent—the serpentine balloon expandable stent; review of mechanical properties and clinical experience” , Astif Organs, 22(3):243-249 (Mar. 1998).
A View of Vascular Stents, by Richard A. Schatz, MD, From the Arizona Heart Institute Foundation , Phoenix, Arizona, Circulation: vol. 79, No. 2, Feb. 1989, pp. 445-457.
The Self-Expanding Mesh Stent, by Ulrich Sigwart, Section IV Chapter 29, pp. 605-610.
SMART TM Stent Brochure, Cordis, a Johnson & Johnson company Copyright 1998.
Starck, E., “First Clinical Experience with the Mernotherrn Vascular Stent”, STENTS State of the Art Future Development, pp. 59-62 (Jun. 1995).
Technical Note Entitled Modifications of Gianturco Expandable Wire Stents, by Barry T. Uchida et al., AJR, vol. 150, May 1988, pp, 1185-1187.
Tracheobronchial Tree: Expandable Metallic Stents Used in Experimental and Clinical Applications\, Work in Progress, by Wallace et al, Radiology, Feb. 1986, pp. 309-312.
U.S. Appl. No. 08/396,569, Brown, filed Mar. 1, 1995.
U.S. Appl. No. 60/076,946, filed Mar. 5, 1998, Tseng et al.
U.S. Appl. No. 10/474,848, Tseng et al., filed Dec. 29, 2003.
International Search Report and Written Opinion, PCT/US2011/052622, mailed Dec. 6, 2011.
Melzer, A. et al., Performance Improvement of Surgical Instrumental Through the Use of Ni-Ti Materials, Proceedings of SMST-94 The First International conference on Shape Memory and Superelastic Technologies, pp. 401-409 (Mar. 7-10, 1994).
Related Publications (1)
Number Date Country
20120226342 A1 Sep 2012 US
Provisional Applications (1)
Number Date Country
61448918 Mar 2011 US